Extracampine hallucinations term was given by
**Question:** Extra pyramidal hallucinations term was given by
A. Charles Darwin
B. David Healy
C. Karl Leonhard
D. Volkmann
**Correct Answer:** D. Volkmann
**Core Concept:** Extra pyramidal hallucinations refer to a group of symptoms characterized by involuntary, uncontrollable movements and sensory perceptions that occur as a side effect of certain medications, particularly dopamine-blocking agents like antipsychotics and anticholinergics. These symptoms are part of a larger group of side effects known as extrapyramidal symptoms (EPS) or Parkinsonism-like reactions (PLR).
**Why the Correct Answer is Right:** Extrapyramidal symptoms were first described by German neurologist, Emil Kraepelin, in 1892, who named them "Extrapyramidal Reactions" (ER). However, the term "extra pyramidal hallucinations" was coined by Volkmann in 1910, specifically referring to the sensory symptoms associated with the motor symptoms.
**Why Each Wrong Option is Incorrect:**
A. Charles Darwin: Darwin was a British naturalist and biologist, famous for his theory of evolution. He has no association with the medical field and specifically the term "extra pyramidal hallucinations".
B. David Healy: Healy is a Welsh psychiatrist, but he is primarily known for his work on the history of psychotropic drugs and the concept of "side-effect chasing" in pharmaceutical research, not the description of extra pyramidal hallucinations.
C. Karl Leonhard: Leonhard is a Swiss psychiatrist and one of the pioneers in the field of psychiatry. While he is known for his work on various psychiatric disorders, the term "extra pyramidal hallucinations" is not associated with his name.
**Clinical Pearl:** Extra pyramidal hallucinations are a manifestation of a broader set of side effects known as extrapyramidal symptoms (EPS) or Parkinsonism-like reactions (PLR). These side effects are commonly observed in patients treated with antipsychotics and anticholinergics, often leading to treatment discontinuation or dose reduction. Understanding the pathophysiology of EPS is essential for recognizing and managing these side effects in clinical practice.